Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia.
Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy.
Chiara
C
Di Pede
Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy.
Stefano
S
Masiero
Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy.
Valentina
V
Bonsangue
Department of Ear-Nose-Throat and Head-Neck Surgery, University of Padova, Padua, Italy.
Rosario Marchese
RM
Ragona
Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy. alessandra.delfelice@unipd.it.
Alessandra
A
Del Felice
D000368:Aged; D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003679:Deglutition / Q000502:physiology; D003680:Deglutition Disorders / Q000188:drug therapy / Q000208:ethnology / Q000534:rehabilitation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D018979:Myositis, Inclusion Body / Q000150:complications*; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A